Machine learning selects a plasma protein panel evaluated for Parkinson’s disease
Source check: Source checked. Not independent scientific confirmation.
Finding: A two-stage study of 391 participants identified a five-protein plasma panel. The authors tested selected proteins in a separate cohort that included Parkinson’s disease, multiple system atrophy and healthy controls.
Technology: Machine-learning feature selection
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning feature selection derived candidate panels from the measured proteomics data.
- Test and result
- The study reports cohort-based discrimination and follow-up protein measurements using immunoassays.
- Limitation / still unknown
- The results do not establish prospective screening benefit or causal involvement of the proteins.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41531-026-01606-2
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.